论文部分内容阅读
目的：观察米非司酮治疗异位妊娠的适应条件。方法：把成功的３６例与失败的８例的临床资料。治疗后变化情况进行对比分析。结果：当血清β－ＨＣＧ＜６０００ ＩＵ／ Ｌ、血β－ＨＣＧ ５日下降率≥３５％，停经天数＜８周，盆腔包块直径＜４ｃｍ、５日包块直径缩小率≥１０％时，米非司酮治疗成功率达９２．３％。结论：在合适的条件下，米非司酮可用于保守治疗异位妊娠，且无任何毒副作用，疗效好。
Objective: To observe the adaptation of mifepristone to ectopic pregnancy. METHODS: The clinical data of 36 successful cases and 8 failed cases were included. After treatment changes were compared. Results: When the serum β-HCG <6000 IU / L, blood β-HCG 5 days decline rate of ≥ 35%, menopause days <8 weeks, pelvic mass diameter <4cm, 5 days mass shrinkage ≥ 10% Mifepristone treatment success rate of 92.3%. Conclusion: Under appropriate conditions, mifepristone can be used for conservative treatment of ectopic pregnancy without any side effects and has good curative effect.